Start for free
Start for free
TB

Thairm Bio

Europe, Edinburgh, City of, United Kingdom, Edinburgh

Description

Thairm Bio is a Trust that invests in early-stage life science companies.

Investor Profile

Thairm Bio has made 11 investments, with 2 in the past 12 months and 45% as lead.

Stage Focus

  • Series Unknown (45%)
  • Seed (27%)
  • Series A (18%)
  • Series B (9%)

Country Focus

  • United Kingdom (82%)
  • United States (18%)

Industry Focus

  • Health Care
  • Biotechnology
  • Wellness
  • Medical
  • Women's
  • Clinical Trials
  • Life Science
  • Internet
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Thairm Bio frequently co-invest with?

Scottish National Investment Bank
Scottish National Investment Bank
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Deepbridge Capital
Deepbridge Capital
Europe, Cheshire, United Kingdom, Chester
Co-Investments: 1
WS
Wexford Science & Technology
North America, Maryland, United States, Baltimore
Co-Investments: 2
Argosy Foundation
Argosy Foundation
North America, Wisconsin, United States, Milwaukee
Co-Investments: 2
SV
SIS Ventures
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 2
Kineticos Ventures
Kineticos Ventures
North America, North Carolina, United States, Morrisville
Co-Investments: 2
Scottish Investment Bank
Scottish Investment Bank
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 2
University of Strathclyde
University of Strathclyde
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
UA
UMass Amherst Rocketry
North America, Massachusetts, United States, Amherst
Co-Investments: 2
Scottish Enterprise
Scottish Enterprise
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 7

What are some of recent deals done by Thairm Bio?

3Daughters

Boston, Massachusetts, United States

3Daughters is a women’s healthcare company developing a new evolutionary intrauterine device (IUD) for contraception.

Health CareWomen's
SeedJul 10, 2024
Amount Raised: $2,700,000
Phlo

London, England, United Kingdom

Phlo is a digital pharmacy that provides secure, real-time, same-day prescription delivery.

Health CareInternetMedicalPharmaceutical
Series UnknownApr 17, 2024
Amount Raised: $11,207,775
EnteroBiotix

Edinburgh, Edinburgh, City of, United Kingdom

EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.

BiotechnologyClinical TrialsHealth CareLife Science
Series BApr 4, 2024
Amount Raised: $29,258,746
3Daughters

Boston, Massachusetts, United States

3Daughters is a women’s healthcare company developing a new evolutionary intrauterine device (IUD) for contraception.

Health CareWomen's
SeedJan 22, 2024
Amount Raised: $2,000,000
Microplate Dx

Glasgow, Glasgow City, United Kingdom

Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.

BiotechnologyHealth CareMedical
SeedSep 11, 2023
Amount Raised: $3,127,013
Pneumagen

Saint Andrews, Fife, United Kingdom

Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.

BiotechnologyHealth CareWellness
Series UnknownJun 1, 2023
Amount Raised: $10,021,032
Phlo

London, England, United Kingdom

Phlo is a digital pharmacy that provides secure, real-time, same-day prescription delivery.

Health CareInternetMedicalPharmaceutical
Series AFeb 2, 2023
Amount Raised: $12,221,144
Pneumagen

Saint Andrews, Fife, United Kingdom

Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.

BiotechnologyHealth CareWellness
Series UnknownJan 19, 2022
Amount Raised: $5,171,320
EnteroBiotix

Edinburgh, Edinburgh, City of, United Kingdom

EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.

BiotechnologyClinical TrialsHealth CareLife Science
Series ASep 7, 2021
Amount Raised: $21,357,923
Pneumagen

Saint Andrews, Fife, United Kingdom

Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.

BiotechnologyHealth CareWellness
Series UnknownJan 21, 2021
Amount Raised: $3,432,161
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator